Form 4 for AORT ARTIVION, INC.
Accepted 2026-02-25 00:00:00 ET · period of report 2026-02-23 · accession 0001628280-26-011837 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-02-25 | 2026-02-23+ | AORT | Stanton Marshall S. | SVP, Clinical, MD Affair | S - Sale | $36.94 | -3,682 | 41.9K | -8% | -$136.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-23 | S | D | 2,423 | $37.59 | 43,180 | D | — | — | (F1) These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction. |
| 2 | Common | Common Stock | 2026-02-24 | S | D | 1,259 | $35.69 | 41,921 | D | — | — | (F2) These shares were sold upon the vesting of restricted stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction. |